Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew E Hendifar

Showing results (11-20 of 83) with videos related to

Pageof 9
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 30, 2026
The Equivalents Are Coming! Developing a Shared Nomenclature for Radiopharmaceutical Therapy of Neuroendocrine Tumors, Prostate Cancer, and BeyondAman Chauhan, Andrew E Hendifar, Ghassan El-Haddad, et al.
Journal of Gastrointestinal Oncology|March 23, 2018
Cachexia, and not obesity, prior to pancreatic cancer diagnosis worsens survival and is negated by chemotherapyAndrew E Hendifar, Jonathan I Chang, Brian Z Huang, et al.
Oncology Letters|April 30, 2017
Statins and pancreatic cancerJun Gong, Esha Sachdev, Lori A Robbins, et al.
Journal of Surgical Oncology|September 5, 2023
Socioeconomic disparities in patients with small bowel neuroendocrine tumorsTimothy P DiPeri, Nicholas Manguso, Jun Gong, et al.
Current Treatment Options in Oncology|May 31, 2012
Moving beyond response criteria: new measures of success in the treatment of sarcomasAndrew E Hendifar, Elke Ahlmann, Daniel C Allison, et al.
Cureus|October 5, 2020
Remote Oncology Care: Review of Current Technology and Future DirectionsBradley A McGregor, Gregory A Vidal, Sumit A Shah, et al.
Pancreas|July 21, 2018
Utility of Endoscopic Ultrasound-Guided Biopsy for Next-Generation Sequencing of Pancreatic Exocrine MalignanciesBrent K Larson, Richard Tuli, Laith H Jamil, et al.
Endocrine Oncology (Bristol, England)|June 5, 2026
Pathogenic germline variants identified in pNEN patients during genetic testingTara Arouchian, Alexandra Gangi, Ka Wing Fung, et al.
Cancers|March 13, 2024
Glutamine Supplementation as an Anticancer Strategy: A Potential Therapeutic Alternative to the ConventionHayato Muranaka, Rasaq Akinsola, Sandrine Billet, et al.
Annals of Surgical Oncology|May 13, 2020
Midgut Neuroendocrine Tumors with Liver-only Metastases: Benefit of Primary Tumor ResectionAlexandra Gangi, Nicholas Manguso, Jun Gong, et al.
Pageof 9

Showing results (11-20 of 83) with videos related to

Sort By:
Pageof 9
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 30, 2026
The Equivalents Are Coming! Developing a Shared Nomenclature for Radiopharmaceutical Therapy of Neuroendocrine Tumors, Prostate Cancer, and BeyondAman Chauhan, Andrew E Hendifar, Ghassan El-Haddad, et al.
Journal of Gastrointestinal Oncology|March 23, 2018
Cachexia, and not obesity, prior to pancreatic cancer diagnosis worsens survival and is negated by chemotherapyAndrew E Hendifar, Jonathan I Chang, Brian Z Huang, et al.
Oncology Letters|April 30, 2017
Statins and pancreatic cancerJun Gong, Esha Sachdev, Lori A Robbins, et al.
Journal of Surgical Oncology|September 5, 2023
Socioeconomic disparities in patients with small bowel neuroendocrine tumorsTimothy P DiPeri, Nicholas Manguso, Jun Gong, et al.
Current Treatment Options in Oncology|May 31, 2012
Moving beyond response criteria: new measures of success in the treatment of sarcomasAndrew E Hendifar, Elke Ahlmann, Daniel C Allison, et al.
Cureus|October 5, 2020
Remote Oncology Care: Review of Current Technology and Future DirectionsBradley A McGregor, Gregory A Vidal, Sumit A Shah, et al.
Pancreas|July 21, 2018
Utility of Endoscopic Ultrasound-Guided Biopsy for Next-Generation Sequencing of Pancreatic Exocrine MalignanciesBrent K Larson, Richard Tuli, Laith H Jamil, et al.
Endocrine Oncology (Bristol, England)|June 5, 2026
Pathogenic germline variants identified in pNEN patients during genetic testingTara Arouchian, Alexandra Gangi, Ka Wing Fung, et al.
Cancers|March 13, 2024
Glutamine Supplementation as an Anticancer Strategy: A Potential Therapeutic Alternative to the ConventionHayato Muranaka, Rasaq Akinsola, Sandrine Billet, et al.
Annals of Surgical Oncology|May 13, 2020
Midgut Neuroendocrine Tumors with Liver-only Metastases: Benefit of Primary Tumor ResectionAlexandra Gangi, Nicholas Manguso, Jun Gong, et al.
Pageof 9